These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 34018053)

  • 1. Preclinical trial of a MAP4K4 inhibitor to reduce infarct size in the pig: does cardioprotection in human stem cell-derived myocytes predict success in large mammals?
    Te Lintel Hekkert M; Newton G; Chapman K; Aqil R; Downham R; Yan R; Merkus D; Whitlock G; Lane CAL; Cawkill D; Perrior T; Duncker DJ; Schneider MD
    Basic Res Cardiol; 2021 May; 116(1):34. PubMed ID: 34018053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MAP4K4 Inhibition Promotes Survival of Human Stem Cell-Derived Cardiomyocytes and Reduces Infarct Size In Vivo.
    Fiedler LR; Chapman K; Xie M; Maifoshie E; Jenkins M; Golforoush PA; Bellahcene M; Noseda M; Faust D; Jarvis A; Newton G; Paiva MA; Harada M; Stuckey DJ; Song W; Habib J; Narasimhan P; Aqil R; Sanmugalingam D; Yan R; Pavanello L; Sano M; Wang SC; Sampson RD; Kanayaganam S; Taffet GE; Michael LH; Entman ML; Tan TH; Harding SE; Low CMR; Tralau-Stewart C; Perrior T; Schneider MD
    Cell Stem Cell; 2019 Apr; 24(4):579-591.e12. PubMed ID: 30853557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective protection of human cardiomyocytes from anthracycline cardiotoxicity by small molecule inhibitors of MAP4K4.
    Golforoush PA; Narasimhan P; Chaves-Guerrero PP; Lawrence E; Newton G; Yan R; Harding SE; Perrior T; Chapman KL; Schneider MD
    Sci Rep; 2020 Jul; 10(1):12060. PubMed ID: 32694738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Large Cardiac Muscle Patches Engineered From Human Induced-Pluripotent Stem Cell-Derived Cardiac Cells Improve Recovery From Myocardial Infarction in Swine.
    Gao L; Gregorich ZR; Zhu W; Mattapally S; Oduk Y; Lou X; Kannappan R; Borovjagin AV; Walcott GP; Pollard AE; Fast VG; Hu X; Lloyd SG; Ge Y; Zhang J
    Circulation; 2018 Apr; 137(16):1712-1730. PubMed ID: 29233823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Y-27632 preconditioning enhances transplantation of human-induced pluripotent stem cell-derived cardiomyocytes in myocardial infarction mice.
    Zhao M; Fan C; Ernst PJ; Tang Y; Zhu H; Mattapally S; Oduk Y; Borovjagin AV; Zhou L; Zhang J; Zhu W
    Cardiovasc Res; 2019 Feb; 115(2):343-356. PubMed ID: 30107391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MMI-0100 inhibits cardiac fibrosis in myocardial infarction by direct actions on cardiomyocytes and fibroblasts via MK2 inhibition.
    Xu L; Yates CC; Lockyer P; Xie L; Bevilacqua A; He J; Lander C; Patterson C; Willis M
    J Mol Cell Cardiol; 2014 Dec; 77():86-101. PubMed ID: 25257914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclin D2 Overexpression Enhances the Efficacy of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Myocardial Repair in a Swine Model of Myocardial Infarction.
    Zhao M; Nakada Y; Wei Y; Bian W; Chu Y; Borovjagin AV; Xie M; Zhu W; Nguyen T; Zhou Y; Serpooshan V; Walcott GP; Zhang J
    Circulation; 2021 Jul; 144(3):210-228. PubMed ID: 33951921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac muscle patches containing four types of cardiac cells derived from human pluripotent stem cells improve recovery from cardiac injury in mice.
    Lou X; Tang Y; Ye L; Pretorius D; Fast VG; Kahn-Krell AM; Zhang J; Zhang J; Qiao A; Qin G; Kamp T; Thomson JA; Zhang J
    Cardiovasc Res; 2023 May; 119(4):1062-1076. PubMed ID: 36647784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonocclusive multivessel intracoronary infusion of allogeneic cardiosphere-derived cells early after reperfusion prevents remote zone myocyte loss and improves global left ventricular function in swine with myocardial infarction.
    Suzuki G; Weil BR; Young RF; Fallavollita JA; Canty JM
    Am J Physiol Heart Circ Physiol; 2019 Aug; 317(2):H345-H356. PubMed ID: 31125261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of human induced pluripotent stem-cell derived cardiomyocytes with human mesenchymal stem cells following acute myocardial infarction.
    Citro L; Naidu S; Hassan F; Kuppusamy ML; Kuppusamy P; Angelos MG; Khan M
    PLoS One; 2014; 9(12):e116281. PubMed ID: 25551230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. β3 adrenergic receptor selective stimulation during ischemia/reperfusion improves cardiac function in translational models through inhibition of mPTP opening in cardiomyocytes.
    García-Prieto J; García-Ruiz JM; Sanz-Rosa D; Pun A; García-Alvarez A; Davidson SM; Fernández-Friera L; Nuno-Ayala M; Fernández-Jiménez R; Bernal JA; Izquierdo-Garcia JL; Jimenez-Borreguero J; Pizarro G; Ruiz-Cabello J; Macaya C; Fuster V; Yellon DM; Ibanez B
    Basic Res Cardiol; 2014 Jul; 109(4):422. PubMed ID: 24951958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-cadherin overexpression enhances the reparative potency of human-induced pluripotent stem cell-derived cardiac myocytes in infarcted mouse hearts.
    Lou X; Zhao M; Fan C; Fast VG; Valarmathi MT; Zhu W; Zhang J
    Cardiovasc Res; 2020 Mar; 116(3):671-685. PubMed ID: 31350544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expandable human cardiovascular progenitors from stem cells for regenerating mouse heart after myocardial infarction.
    Schwach V; Gomes Fernandes M; Maas S; Gerhardt S; Tsonaka R; van der Weerd L; Passier R; Mummery CL; Birket MJ; Salvatori DCF
    Cardiovasc Res; 2020 Mar; 116(3):545-553. PubMed ID: 31287499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose Humanin analogue applied during ischemia exerts cardioprotection against ischemia/reperfusion injury by reducing mitochondrial dysfunction.
    Thummasorn S; Shinlapawittayatorn K; Chattipakorn SC; Chattipakorn N
    Cardiovasc Ther; 2017 Oct; 35(5):. PubMed ID: 28726291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retroinfusion of embryonic endothelial progenitor cells attenuates ischemia-reperfusion injury in pigs: role of phosphatidylinositol 3-kinase/AKT kinase.
    Kupatt C; Hinkel R; Lamparter M; von Brühl ML; Pohl T; Horstkotte J; Beck H; Müller S; Delker S; Gildehaus FJ; Büning H; Hatzopoulos AK; Boekstegers P
    Circulation; 2005 Aug; 112(9 Suppl):I117-22. PubMed ID: 16159802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B7-33, a Functionally Selective Relaxin Receptor 1 Agonist, Attenuates Myocardial Infarction-Related Adverse Cardiac Remodeling in Mice.
    Devarakonda T; Mauro AG; Guzman G; Hovsepian S; Cain C; Das A; Praveen P; Hossain MA; Salloum FN
    J Am Heart Assoc; 2020 Apr; 9(8):e015748. PubMed ID: 32295457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obestatin affords cardioprotection to the ischemic-reperfused isolated rat heart and inhibits apoptosis in cultures of similarly stressed cardiomyocytes.
    Alloatti G; Arnoletti E; Bassino E; Penna C; Perrelli MG; Ghé C; Muccioli G
    Am J Physiol Heart Circ Physiol; 2010 Aug; 299(2):H470-81. PubMed ID: 20525876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Intracoronary Metformin on Myocardial Infarct Size in Swine.
    Techiryan G; Weil BR; Palka BA; Canty JM
    Circ Res; 2018 Sep; 123(8):986-995. PubMed ID: 30355033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MMI-0100 Inhibits Cardiac Fibrosis in a Mouse Model Overexpressing Cardiac Myosin Binding Protein C.
    Meng Q; Bhandary B; Osinska H; James J; Xu N; Shay-Winkler K; Gulick J; Willis MS; Lander C; Robbins J
    J Am Heart Assoc; 2017 Sep; 6(9):. PubMed ID: 28871043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional Effects of a Tissue-Engineered Cardiac Patch From Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes in a Rat Infarct Model.
    Wendel JS; Ye L; Tao R; Zhang J; Zhang J; Kamp TJ; Tranquillo RT
    Stem Cells Transl Med; 2015 Nov; 4(11):1324-32. PubMed ID: 26371342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.